封面
市场调查报告书
商品编码
1271215

虚拟临床试验市场,实验各类型,各阶段,各企业规模,各治疗领域,各地区-规模,占有率,展望,机会分析,2023年~2030年

Virtual Clinical Trials Market, By Study Type, By Phases, By Company Size, By Therapeutic Area, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3个工作天内

价格
简介目录

虚拟临床试验是一种使用技术和线上社交参与平台进行临床研究的相对较新的方法。虚拟试验有可能推动临床研究方法的重大数位化变革,从而创建一个改进的以患者为中心的生态系统。虚拟临床试验以数位方式授权临床试验过程。

疾病负担增加、虚拟临床试验采用率的飙升、远程医疗采用率的上升、新技术采用率的上升、医疗保健数位化的上升、技术进步以及 COVID-19(大流行)的爆发预计将是成长的主要因素,在预测期内推动全球虚拟临床试验市场的成长。

本报告对全球虚拟临床试验市场进行了深入分析,并提供了预测期(2023-2030年)的市场规模(百万美元)和年复合成长率(CAGR%),以2022年为基准年。

目录:

第1章 调查的目的与前提条件

  • 调查的目的
  • 前提条件
  • 简称

第2章 市场展望

  • 报告概要
    • 市场定义和规模
  • 摘要整理
    • 市场概述:各研究类型
    • 市场概述:各阶段
    • 市场概述:各企业规模
    • 市场概述:各治疗领域
    • 市场概述:各地区
  • Coherent Opportunity Map(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 全球虚拟临床试验数增加
    • 虚拟临床试验相关的课题
    • 疾病负担增加和COVID-19发生
  • 影响度分析
  • 主要的焦点
  • 法律规章情境
  • 产品销售/核准
  • PEST分析
  • PORTER的分析
  • 合併、收购情境

第4章 虚拟临床试验的全球市场-冠状病毒(COVID-19)大流行造成的的影响

  • 关于COVID-19流行病学
  • 供给侧和需求侧的分析
  • 经济影响

第5章 虚拟临床试验的全球市场,各实验类型,2017年~2030年

  • 介入
  • 其他

第6章 虚拟临床试验的全球市场,各阶段,2017年~2030年

  • 后期阶段
  • 初期阶段

第7章 虚拟临床实验的全球市场,各企业规模,2017年~2030年

  • 中坚、中小企业
  • 大企业

第8章 虚拟临床试验的全球市场:各治疗领域,2017年~2030年

  • 肿瘤学
  • 罕见疾病、遗传性疾病
  • 中枢神经系统
  • 免疫学
  • 其他

第9章 虚拟临床试验的全球市场,各地区,2017年~2030年

  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东、非洲地区

第10章 竞争情形

  • Delve Health
  • Clario
  • Clinical Ink
  • Castor
  • Accenture
  • Thread
  • Science 37
  • Medable
  • Dassault Systemes
  • eElinicalHealth(CLINPAL)

第11章 Section

  • 关于调查手法
  • 关于出版社
简介目录
Product Code: CMI5658

Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.

Market Dynamics:

Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.

For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.

Key features of the study:

  • This report provides in-depth analysis of the global virtual clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systemes, and eElinicalHealth (CLINPAL), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.

Detailed Segmentation:

  • Global Virtual Clinical Trials Market, By Study Type:
    • Interventional
    • Others
  • Global Virtual Clinical Trials Market, By Phases:
    • Late Stage
    • Early Stage
  • Global Virtual Clinical Trials Market, By Company Size:
    • Small- & Mid-sized
    • Large-sized
  • Global Virtual Clinical Trials Market, By Therapeutic Area:
    • Oncology
    • Rare & Genetic Diseases
    • CNS
    • Immunology
    • Others
  • Global Virtual Clinical Trials Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Delve Health
    • Clario
    • Clinical Ink
    • Castor
    • Accenture
    • Thread
    • Science 37
    • Medable
    • Dassault Systemes
    • eElinicalHealth (CLINPAL)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Study Type
    • Market Snapshot, By Phases
    • Market Snapshot, By Company Size
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in number of virtual clinical trials worldwide
    • Challenges associated with virtual clinical trials
    • Growing burden of diseases and outbreak of COVID-19
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Virtual Clinical Trials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Virtual Clinical Trials Market, By Study Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Interventional
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Virtual Clinical Trials Market, By Phases, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Late Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Early Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Virtual Clinical Trials Market, By Company Size, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Small- & Mid-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Large-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

8. Global Virtual Clinical Trials Market, By Therapeutic Area, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Rare & Genetic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

9. Global Virtual Clinical Trials Market, By Geography, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)

10. Competitive Landscape

  • Delve Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clario
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clinical Ink
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Castor
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Accenture
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thread
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Science 37
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medable
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dassault Systemes
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • eElinicalHealth (CLINPAL)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us